Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
申请人:Zhao Cunxiang
公开号:US20050234046A1
公开(公告)日:2005-10-20
Aryl sulfonamide and sulfonyl compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors
申请人:Malecha James W.
公开号:US20090143396A1
公开(公告)日:2009-06-04
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
ARYL SULFONAMIDE AND SULFONYL COMPOUNDS AS MODULATORS OF PPAR AND METHODS OF TREATING METABOLIC DISORDERS
申请人:Kalypsys, Inc.
公开号:EP1735280A1
公开(公告)日:2006-12-27
[EN] ARYL SULFONAMIDE AND SULFONYL COMPOUNDS AS MODULATORS OF PPAR AND METHODS OF TREATING METABOLIC DISORDERS<br/>[FR] COMPOSES ARYL SULFONAMIDE ET SULFONYL UTILISES COMME MODULATEURS DE PPAR, ET PROCEDES DE TRAITEMENT DE TROUBLES METABOLIQUES
申请人:KALYPSYS INC
公开号:WO2005115983A1
公开(公告)日:2005-12-08
Aryl sulfonamide and sulfonyl compounds of formula (I) as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
[EN] SULFONYL-SUBSTITUTED ARYL COMPOUNDS AS MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS<br/>[FR] COMPOSES D'ARYLE SUBSTITUES PAR DU SULFONYL EN TANT QUE MODULATEURS DE RECEPTEURS ACTIVES PAR LES INDUCTEURS DE LA PROLIFERATION DES PEROXYSOMES
申请人:KALYPSYS INC
公开号:WO2007047431A2
公开(公告)日:2007-04-26
[EN] Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed. [FR] L'invention concerne des composés utilisés en tant que modulateurs de récepteurs activés par les inducteurs de la prolifération des péroxysomes (PPAR), des compositions pharmaceutiques les contenant, et des méthodes de traitement de maladie au moyen desdits composés.